Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften E-learning Web-tv Video Audio
Tips voor Mijn BSL
UITGEBREID ZOEKEN
Inloggen
Top
Quality of Life Research
Gepubliceerd in: Quality of Life Research 8/2023

17-01-2023 | Review

The current use of the EORTC QLQ-NMIBC24 and QLQ-BLM30 questionnaires for the assessment of health-related quality of life in bladder cancer patients: a systematic review

Auteurs: E. Rammant, L. Fox, K. Beyer, N. K. Aaronson, R. Chaloner, S. De Padova, F. Liedberg, L. M. Wintner, K. Decaestecker, V. Fonteyne, N. Perdek, H. Wylie, J. W. F. Catto, T. M. Ripping, B. Holzner, M. Van Leeuwen, M. Van Hemelrijck, the EORTC Quality of Life Group

Gepubliceerd in: Quality of Life Research | Uitgave 8/2023

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Abstract

Purpose

Investigating the use of the EORTC bladder cancer (BC) modules by evaluating: (a) study contexts/designs; (b) languages/countries in which the modules were administered; (c) their acceptance by patients/investigators; and (d) their psychometric properties.

Methods

A systematic review was performed with studies from 1998 until 20/10/2021 in five databases. Articles/conference abstracts using the EORTC-QLQBLM30 (muscle invasive BC) and the EORTC-QLQNMIBC24 (previously referred to as QLQ-BLS24; non-muscle invasive BC) were included. Two authors independently screened titles/abstracts/full-texts and performed data extraction.

Results

A total of 76 eligible studies were identified. Most studies included the BLM30 (n = 53), were in a urological surgery context (n = 41) and were cross-sectional (n = 35) or prospective (n = 30) in design. The BC modules were administered in 14 languages across 19 countries. Missing data were low-moderate for all non-sex related questions (< 1% to 15%). Sex-related questions had higher rates of missing data (ranging from 6.9% to 84%). Most investigators did not use all scales of the questionnaires. One validation study for the original BLS24 led to the development of the NMIBC24, which adopted a new scale structure for which good structural validity was confirmed (n = 3). Good reliability and validity was shown for the NMIBC24 module, except for malaise and bloating/flatulence scales. Psychometric evidence for BLM30 is lacking.

Conclusion

These results provide insight into how the EORTC BC quality of life modules could be further improved. Current work is ongoing to update the modules and to determine if the two modules can be combined into a single questionnaire that works well in both the NMIBC and MIBC settings.
volgende artikel Patient-reported outcome measures for uncomplicated urinary tract infections in women: a systematic review
Literatuur
1.
Mason, S. J., Downing, A., Wright, P., Hounsome, L., Bottomley, S. E., Corner, J., Richards, M., Catto, J. W., & Glaser, A. W. (2018). Health-related quality of life after treatment for bladder cancer in England. British Journal of Cancer, 118(11), 1518–1528.PubMedPubMedCentralCrossRef
2.
Van Hemelrijck, M., Sparano, F., Josephs, D., Sprangers, M., Cottone, F., & Efficace, F. (2019). Patient-reported outcomes in randomised clinical trials of bladder cancer: An updated systematic review. BMC Urology, 19(1), 86.PubMedPubMedCentralCrossRef
3.
Mason, S. J., Catto, J. W. F., Downing, A., Bottomley, S. E., Glaser, A. W., & Wright, P. (2018). Evaluating patient-reported outcome measures (PROMs) for bladder cancer: A systematic review using the COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) checklist. BJU International, 122(5), 760–773.PubMedPubMedCentralCrossRef
4.
Prinsen, C. A. C., Mokkink, L. B., Bouter, L. M., Alonso, J., Patrick, D. L., de Vet, H. C. W., & Terwee, C. B. (2018). COSMIN guideline for systematic reviews of patient-reported outcome measures. Quality of Life Research, 27(5), 1147–1157.PubMedPubMedCentralCrossRef
5.
6.
Blazeby, J. M., Hall, E., Aaronson, N. K., Lloyd, L., Waters, R., Kelly, J. D., & Fayers, P. (2014). Validation and reliability testing of the EORTC QLQ-NMIBC24 questionnaire module to assess patient-reported outcomes in non-muscle-invasive bladder cancer. European Urology, 66(6), 1148–1156.PubMedPubMedCentralCrossRef
7.
Mansson, A., Henningsohn, L., Steineck, G., & Mansson, W. (2004). Neutral third party versus treating institution for evaluating quality of life after radical cystectomy. European Urology, 46(2), 195–199.PubMedCrossRef
8.
Sogni, F., Brausi, M., Frea, B., Martinengo, C., Faggiano, F., Tizzani, A., & Gontero, P. (2008). Morbidity and quality of life in elderly patients receiving ileal conduit or orthotopic neobladder after radical cystectomy for invasive bladder cancer. Urology, 71(5), 919–923.PubMedCrossRef
9.
Severin, T., Bub, P., Jocham, D., & Kausch, I. (2010). Quality of life after radical cystectomy—An overview and analysis of a contemporary series. Aktuelle Urologie, 41(4), 245–251.PubMedCrossRef
10.
Erber, B., Schrader, M., Miller, K., Schostak, M., Baumunk, D., Lingnau, A., Schrader, A.J., & Jentzmik, F. (2012) Morbidity and Quality of Life in Bladder Cancer Patients following Cystectomy and Urinary Diversion: A Single-Institution Comparison of Ileal Conduit versus Orthotopic Neobladder, Isrn Urology Print 2012 342796
11.
Jensen, B. T., Jensen, J. B., Laustsen, S., Petersen, A. K., Sondergaard, I., & Borre, M. (2014). Multidisciplinary rehabilitation can impact on health-related quality of life outcome in radical cystectomy: Secondary reported outcome of a randomized controlled trial. Journal of Multidisciplinary Healthcare, 7, 301–311.PubMedPubMedCentralCrossRef
12.
Mogensen, K., Christensen, K. B., Vrang, M. L., & Hermann, G. G. (2016). Hospitalization for transurethral bladder resection reduces quality of life in Danish patients with non-muscle-invasive bladder tumour. Scandinavian Journal of Urology, 50(3), 170–174.PubMedCrossRef
13.
Anderson, C. B., Rapkin, B., Reaves, B. C., Sun, A. J., Morganstern, B., Dalbagni, G., Donat, M., Herr, H. W., Laudone, V. P., & Bochner, B. H. (2017). Idiographic quality of life assessment before radical cystectomy. Psycho-Oncology, 26(2), 206–213.PubMedCrossRef
14.
Feuerstein, M. A., Goldstein, L., Reaves, B., Sun, A., Goltzman, M., Morganstern, B. A., Shabsigh, A., Bajorin, D. F., Rosenberg, J. E., Donat, S. M., Herr, H. W., Laudone, V. P., Atkinson, T. M., Li, Y., Dalbagni, G., Rapkin, B., & Bochner, B. H. (2019). Propensity-matched analysis of patient-reported outcomes for neoadjuvant chemotherapy prior to radical cystectomy. World Journal of Urology, 37(11), 2401–2407.PubMedPubMedCentralCrossRef
15.
Normann, C. O., Opheim, R., Andreassen, B. K., Bernklev, T., & Haug, E. S. (2020). Health-related quality-of-life after radical cystectomy among Norwegian men and women compared to the general population. Scandinavian Journal of Urology, 54(3), 181–187.PubMedCrossRef
16.
Park, J., Shin, D. W., Kim, T. H., Jung, S. I., Nam, J. K., Park, S. C., Hong, S., Jung, J. H., Kim, H., & Kim, W. T. (2018). Development and validation of the Korean version of the European organization for research and treatment of cancer quality of life questionnaire for patients with non-muscle invasive bladder cancer: EORTC QLQ-NMIBC24. Cancer Research and Treatment, 50(1), 40–49.PubMedCrossRef
17.
Catto, J. W. F., Downing, A., Mason, S., Wright, P., Absolom, K., Bottomley, S., Hounsome, L., Hussain, S., Varughese, M., Raw, C., Kelly, P., & Glaser, A. W. (2021). Quality of life after bladder cancer: A cross-sectional survey of patient-reported outcomes. European Urology, 79(5), 621–632.PubMedPubMedCentralCrossRef
18.
Ripping, T. M., Westhoff, E., Aaronson, N. K., Van Hemelrijck, M., Rammant, E., Witjes, J. A., Kiemeney, L. A., Aben, K. K. H., & Vrieling, A. (2021). Validation and reliability of the Dutch version of the EORTC QLQ-NMIBC24 questionnaire module for patients with non-muscle-invasive bladder cancer. Journal of Patientreported Outcomes, 5(1), 96.CrossRef
19.
Jung, A., Crandell, J., Nielsen, M. E., Smith, S. K., Palmer, M. H., Bryant, A. L., & Mayer, D. (2017). Predictors of quality of life in non-muscle-invasive bladder cancer survivors. Journal of Clinical Oncology, 35(31 Supplement 1)), 193.CrossRef
20.
Jung, A., Nielsen, M.E., Smith, S.K., Crandell, J., Palmer, M.H., Bryant, A.L., Mayer, D. (2017) Uncertainty, post-traumatic stress, and quality of life in non-muscle-invasive bladder cancer survivors. Journal of Clinical Oncology. Conference 35(15 Supplement 1)
21.
O’Meara, S., Considine, S., Anderson, S., Aboelmagd, M., Connolly, S., Galvin, D., Hegarty, N., & O’Malley, K. J. (2019). Quality of Life in Irish Patients with Non Muscle Invasive Bladder Cancer, European Urology. Supplements, 18(5), e2544.
22.
Mostafid, H., Porta, N., Cresswell, J., Griffiths, T., Kelly, J., Catto, J., Davenport, K., McGrath, J., Cooke, P., Masood, S., Feber, A., Knowles, M., Knight, A., Penegar, S., Wiley, L., Lewis, R., & Hall, E. (2019). 12 month results of CALIBER: A phase II randomised feasibility trial of chemoablation with MMC versus surgical management in low risk (LR) non-muscle invasive bladder cancer (NMIBC). European Urology, Supplements, 18(1), e762–e763.CrossRef
23.
Ripping, T. M., Kiemeney, L. A., Van Hoogstraten, L. M. C., Witjes, J. A., & Aben, K. K. H. (2020). Insight into bladder cancer care: Study protocol of a large nationwide prospective cohort study (BlaZIB). BMC Cancer, 20(1), 1–7.CrossRef
24.
Hart, S., Schover, L., Amiel, G., Lerner, S., & Latini, D. (2009). Fear of recurrence in bladder cancer patients: Preliminary validation of an existing measure in a new population. Journal of Cancer Education, 1, 67.
25.
Hersom, J. I., Gordon, J., Schover, L., Amiel, G., Lerner, S., & Latini, D. (2009). Fear of recurrence and symptoms predicts general HRQOL and psychological distress in nonmuscle-invasive bladder cancer patients. Journal of Cancer Education, 1, 68.
26.
Sapre, N., Wooten, A., Siddons, H., Costello, A. J., Hovens, C. M., Corcoran, N. M., & Anderson, P. (2013). Tumour recurrence and intravesical BCG significantly impact upon health related quality of life in patients undergoing conservative management for superficial bladder cancer. European Urology Supplements, 12(1), e704.CrossRef
27.
Munjampalli, S. K. J. P., Gordon, J., Schover, L. R., Amiel, G. E., Latini, D. M., & Lerner, S. P. (2009). Veterans with nonmuscle-invasive bladder cancer report worse HRQOL than private patients. Journal of Urology, 181(4), 92.CrossRef
28.
Serretta, V., Ruggirello, A., Giaimo, R., Sommatino, F., Billone, V., Allegro, R., & Melloni, D. (2010). Prevention of topic toxicity of BCG with single-dose prulifloxacin. Preliminary results of a randomized pilot study. [Italian], Urologia, 77(4), 240–247.PubMedCrossRef
29.
Van Der Aa, M. N. M., Bekker, M. D., Van Der Kwast, T. H., Essink-Bot, M. L., Steyerberg, E. W., Zwarthoff, E. C., Sen, F. E. F., & Elzevier, H. W. (2009). Sexual function of patients under surveillance for bladder cancer. BJU International, 104(1), 35–40.PubMedCrossRef
30.
Gontero, P., Gurioli, A., Oderda, M., Mehnert, A., Rink, M., Schmid, M., Kluth, L., Pappagallo, G., Sogni, F., Francesco, S., Martorana, G., & Chun, F. (2012). Is there a difference in quality of life between BCG and intravesical chemotherapy? Results of a randomized phase II study. Journal of Urology, 187(4), e218.
31.
Gontero, P., Oderda, M., Mehnert, A., Gurioli, A., Marson, F., Lucca, I., Rink, M., Schmid, M., Kluth, L. A., Pappagallo, G., Sogni, F., Sanguedolce, F., Schiavina, R., Martorana, G., Shariat, S. F., & Chun, F. (2013). The impact of intravesical gemcitabine and 1/3 dose bacillus Calmette–Guerin instillation therapy on the quality of life in patients with nonmuscle invasive bladder cancer: Results of a prospective, randomized, phase II trial. Journal of Urology, 190(3), 857–862.PubMedCrossRef
32.
Lun, X. P., & Jing, J. (2013). Correlation of coping style with quality of life in superficial bladder cancer patients. [Chinese], Chinese Journal of Cancer Prevention and Treatment, 20(22), 1763–1766.
33.
Michielsen, D., & Coomans, D. (2013). Intravesical chemotherapy or immunotherapy for intermediate-risk non-muscle invasive bladder cancer: Does the patient mention a different quality of life? Urology, 82(3), S130–S131.
34.
Bolat, D., Celik, S., Aydin, M. E., Aydogdu, O., Gunlusoy, B., Degirmenci, T., & Dincel, C. (2018). Assessment of the quality of life and sexual functions of patients followed-up for non-muscle invasive bladder cancer: Preliminary results of the prospective-descriptive study. Turkish Journal of Urology, 44(5), 393–398.PubMedCrossRef
35.
Cerruto, M. A., D’Elia, C., Siracusano, S., Saleh, O., Gacci, M., Cacciamani, G., De Marco, V., Porcaro, A. B., Balzarro, M., Niero, M., Lonardi, C., Iafrate, M., Bassi, P., Imbimbo, C., Racioppi, M., Talamini, R., Ciciliato, S., Serni, S., Carini, M., … Artibani, W. (2017). Health-related quality of life after radical cystectomy: A cross-sectional study with matched-pair analysis on ileal conduit vs ileal orthotopic neobladder diversion. Urology, 108, 82–89.PubMedCrossRef
36.
D’Agostino, D., Racioppi, M., Pugliese, D., Ragonese, M., Di Gianfrancesco, L., Filianoti, A., Palermo, G., Belgrano, E., Siracusano, S., Niero, M., Imbimbo, C., Iafrate, M., Artibani, W., Cerruto, M. A., Talamini, R., & Bassi, P. (2016). Postoperative quality of life in patients with ileal neobladder at short- intermediate-and long-term follow-up. Urologia Internationalis, 97(1), 54–60.PubMedCrossRef
37.
Tostivint, V., Verhoest, G., Cabarrou, B., Gas, J., Coloby, P., Zgheib, J., Thoulouzan, M., Soulie, M., Game, X., Beauval, J. B., Pons-Tostivint, E., & Roumiguie, M. (2021). Quality of life and functional outcomes after radical cystectomy with ileal orthotopic neobladder replacement for bladder cancer: A multicentre observational study. World journal of urology, 39(7), 2525–2530.PubMedCrossRef
38.
Westerman, M. E., Kokorovic, A., Wang, X. S., Lim, A., Garcia-Gonzalez, A., Seif, M., Wang, R., Kamat, A. M., Dinney, C. P. N., & Navai, N. (2020). Radical cystectomy and perioperative sexual function: A cross-sectional analysis. Journal of Sexual Medicine, 17(10), 1995–2004.PubMedCrossRef
39.
Siracusano, S., Niero, M., Lonardi, C., Cerruto, M. A., Ciciliato, S., Toffoli, L., Visalli, F., Massidda, D., Iafrate, M., Artibani, W., Bassi, P., Imbimbo, C., Racioppi, M., Talamini, R., D’Elia, C., Cacciamani, G., De Marchi, D., Silvestri, T., Verze, P., & Belgrano, E. (2014). Development of a questionnaire specifically for patients with Ileal Orthotopic Neobladder (IONB). Health and Quality of Life Outcomes, 12(1), 1–12.CrossRef
40.
Taarnhoj, G. A., Lindberg, H., Johansen, C., & Pappot, H. (2021). Patient-reported outcomes, health-related quality of life, and clinical outcomes for urothelial cancer patients receiving chemo-or immunotherapy: A real-life experience. Journal of Clinical Medicine, 10(9), 1852.PubMedPubMedCentralCrossRef
41.
Volz, Y., Eismann, L., Pfitzinger, P. L., Jokisch, J. F., Schulz, G., Rodler, S., Buchner, A., Schlenker, B., Stief, C. G., & Kretschmer, A. (2021). Salvage cystectomy and ileal conduit urinary diversion as a last-line option for benign diseases-perioperative safety and postoperative health-related quality of life. Neurourology and Urodynamics, 40(5), 1154–1164.PubMedCrossRef
42.
Guren, M. G., Wiig, J. N., Dueland, S., Tveit, K. M., Fossa, S. D., Waehre, H., & Giercksky, K. E. (2001). Quality of life in patients with urinary diversion after operation for locally advanced rectal cancer. European Journal of Surgical Oncology, 27(7), 645–651.PubMedCrossRef
43.
Gacci, M., Saleh, O., Cai, T., Gore, J. L., D’Elia, C., Minervini, A., Masieri, L., Giannessi, C., Lanciotti, M., Varca, V., Simonato, A., Serni, S., Carmignani, G., & Carini, M. (2013). Quality of life in women undergoing urinary diversion for bladder cancer: Results of a multicenter study among long-term disease-free survivors. Health and Quality of Life Outcomes, 11(1), 1–6.CrossRef
44.
Abozaid, M., Zahran, M., Alserafy, F., Tan, W., Baker, H., & Kelly, J. (2017). Quality of life outcome in bladder cancer patients after robotic radical cystectomy and intracorporeal urinary diversion. Journal of Clinical Urology, 10((2 Supplement 1)), 17–19.
45.
Mak, K.S., Smith, A., Eidelman,v, Clayman, R.H., Cheng, J.S., Matthews, J., Niemierko, A., Nielsen, M.E., Feldman, A.S., Lee, R.J., Zietman, A.L., Shipley, W.U., Chen, R.C., Milowsky, M.I., Efstathiou, J.A. (2015) Quality of life in longterm survivors of muscle-invasive bladder cancer, Journal of Clinical Oncology. Conference 33(7 SUPPL. 1)
46.
Atkinson, T. M., Bochner, B. H., Li, Y., & Rapkin, B. D. (2018). Challenges of measuring patient-reported urinary function in cystectomy patients. Quality of Life Research, 27(Supplement 1), S125–S126.
47.
Singer, S., Ziegler, C., Schwalenberg, T., Hinz, A., Götze, H., & Schulte, T. (2013). Quality of life in patients with muscle invasive and non-muscle invasive bladder cancer. Supportive Care in Cancer, 21(5), 1383–1393.PubMedCrossRef
48.
Jung, A., Nielsen, M. E., Crandell, J. L., Palmer, M. H., Bryant, A. L., Smith, S. K., & Mayer, D. K. (2019). Quality of life in non-muscle-invasive bladder cancer survivors: A systematic review. Cancer Nursing, 42(3), E21-e33.PubMedCrossRef
49.
Rammant, E., Van Wilder, L., Van Hemelrijck, M., Pauwels, N. S., Decaestecker, K., Van Praet, C., Bultijnck, R., Ost, P., Van Vaerenbergh, T., & Verhaeghe, S. (2020). Health-related quality of life overview after different curative treatment options in muscle-invasive bladder cancer: An umbrella review. Quality of Life Research, 29, 2887–2910.PubMedCrossRef
50.
van Leeuwen, M., Kieffer, J.M., Efficace, F., Fosså, S.D., Bolla, M., Collette, L., Colombel, M., De Giorgi, U., Holzner, B., van de Poll-Franse, L.V., van Poppel, H., White, J., de Wit, R. Osanto, S., Aaronson, N.K. (2017) R. for the European Organisation for, G. Treatment of Cancer Quality of Life, G. Genito-Urinary Cancers, G. Radiation Oncology, N.T.C.S.G. and the, International evaluation of the psychometrics of health-related quality of life questionnaires for use among long-term survivors of testicular and prostate cancer, Health and Quality of Life Outcomes 15(1) 97.
51.
Cerruto, M. A., D’Elia, C., De Marchi, D., De Marco, V., Cavalleri, S., Novella, G., Rubilotta, E., Sarti, A., & Artibani, W. (2013). Complications and quality of life after radical cystectomy and urinary diversion. Neurourology and Urodynamics, 32(SUPPL.1), S18–S19.
Metagegevens
Titel
The current use of the EORTC QLQ-NMIBC24 and QLQ-BLM30 questionnaires for the assessment of health-related quality of life in bladder cancer patients: a systematic review
Auteurs
E. Rammant
L. Fox
K. Beyer
N. K. Aaronson
R. Chaloner
S. De Padova
F. Liedberg
L. M. Wintner
K. Decaestecker
V. Fonteyne
N. Perdek
H. Wylie
J. W. F. Catto
T. M. Ripping
B. Holzner
M. Van Leeuwen
M. Van Hemelrijck
the EORTC Quality of Life Group
Publicatiedatum
17-01-2023
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 8/2023
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-022-03335-4

Andere artikelen Uitgave 8/2023

Quality of Life Research 8/2023 Naar de uitgave

OriginalPaper

Glycemic status and health-related quality of life (HRQOL) in populations at risk of diabetes in two Latin American cities

OriginalPaper

Patient-reported outcome measures for uncomplicated urinary tract infections in women: a systematic review

OriginalPaper

Sensitivity to change of generic preference-based instruments (EQ-5D-3L, EQ-5D-5L, and HUI3) in the context of treatment for people with prescription-type opioid use disorder in Canada

Commentary

Implications of the syntheses on definition, theory, and methods conducted by the Response Shift – in Sync Working Group

OriginalPaper

Modifying the social responsiveness scale for adaptive administration

OriginalPaper

Suitability of the animated activity questionnaire for use as computer adaptive test: establishing the AAQ-CAT